11
MediBrief | February 2025
DIABETES AND ITS PARTNERS: MANAGING HEART & KIDNEY HEALTH
Cardiovascular Risk and Type 2 Diabetes: What’s new? Dr. John Anderson discusses recent trials, including semaglutide, tirzepatide, and AI innovations, of heart disease prevention and treatment. SHAPING THE FUTURE
MediBrief I.M & ENDOCRINE
Made with FlippingBook - professional solution for displaying marketing and sales documents online